A high brightness microstructured anode X-ray source for clinical phase contrast imaging

Information

  • Research Project
  • 9543634
  • ApplicationId
    9543634
  • Core Project Number
    R44EB023284
  • Full Project Number
    4R44EB023284-02
  • Serial Number
    023284
  • FOA Number
    PA-14-071
  • Sub Project Id
  • Project Start Date
    8/1/2015 - 8 years ago
  • Project End Date
    8/31/2019 - 4 years ago
  • Program Officer Name
    SHABESTARI, BEHROUZ
  • Budget Start Date
    9/30/2017 - 6 years ago
  • Budget End Date
    8/31/2018 - 5 years ago
  • Fiscal Year
    2017
  • Support Year
    02
  • Suffix
  • Award Notice Date
    9/26/2017 - 6 years ago
Organizations

A high brightness microstructured anode X-ray source for clinical phase contrast imaging

X-ray phase contrast imaging (XPCI) is widely regarded as one of the most exciting techniques to have emerged in x-ray physics, and has potential to significantly change the face of biomedical imaging. XPCI, which is based on the refraction of X-rays rather than their absorption, can provide up to 1000 times greater contrast in soft tissues than absorption contrast, which is the current method employed by x-ray equipment. The technique offers enormous potential for earlier diagnosis of diseases and visualization of features currently not visible through conventional techniques, as well as dramatic reduction in dosage to enable safer screening for cancer. Of the several approaches to XPCI, Talbot interferometry is considered to have the most potential for clinical use, as it does not require a synchrotron source. However, the current approach to Talbot phase contrast requires a grating placed near a conventional laboratory X-ray source (the addition of the source grating is called the Talbot-Lau technique). This has led to limits on the X-ray energies used in Talbot-Lau interferometers of less than <20 keV, which has restricted its use (35-80 keV being more optimal for clinical applications), in addition to reduced source efficiency. We propose to develop a high brightness X-ray source that is optimized to enable clinical Talbot interferometers at the higher energies that are relevant to clinical applications. The source employs a novel microstructured anode, which is comprised of an array of tungsten micron-sized X-ray emitters embedded in a material of excellent thermal conductivity and low density (diamond). These micro-emitters act as an array of small sources, which would remove the need for the source grating, and the inclusion of diamond provides superior thermal properties for high brightness. The proposed Phase I 9-month project is a proof-of-principle demonstration that the novel microstructured anode can be manufactured and would provide the desired thermal benefits and x-ray output, and the proposed Phase II 24-month project would produce two working prototypes of the source.

IC Name
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
  • Activity
    R44
  • Administering IC
    EB
  • Application Type
    4
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    942194
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    286
  • Ed Inst. Type
  • Funding ICs
    NIBIB:942194\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SIGRAY, INC.
  • Organization Department
  • Organization DUNS
    079183051
  • Organization City
    CONCORD
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94520
  • Organization District
    UNITED STATES